Drug Shortage Report for APO-RIZATRIPTAN

Last updated on 2018-01-10 History
Report ID 14560
Drug Identification Number 02393468
Brand name APO-RIZATRIPTAN
Common or Proper name RIZATRIPTAN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 6 BLS
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-06-29
Estimated end date
Actual end date 2018-01-05
Shortage status Resolved
Updated date 2018-01-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2018-01-10 French Compare
v13 2018-01-10 English Compare
v12 2018-01-08 French Compare
v11 2018-01-08 English Compare
v10 2017-09-22 French Compare
v9 2017-09-22 English Compare
v8 2017-08-18 French Compare
v7 2017-08-18 English Compare
v6 2017-08-01 French Compare
v5 2017-08-01 English Compare
v4 2017-07-17 French Compare
v3 2017-07-17 English Compare
v2 2017-07-04 French Compare
v1 2017-07-04 English Compare

Showing 1 to 14 of 14